The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS

NCT03306381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2019-12-10

No results posted yet for this study

Summary

The aim of the present study is to research whether subjects with irritable bowel syndrome (IBS) display epigenetic/genetic changes or altered microbiota compared to a non-IBS control group. Further, we will investigate if these parameters as well as subjective IBS symptoms are affected by a 4-week long dietary intervention within the IBS patient group.

Conditions

  • IBS - Irritable Bowel Syndrome

Interventions

OTHER

Dietary intervention

Elimination of certain products.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Bodil Ohlsson, MD, PhD · Region Skane

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306381 on ClinicalTrials.gov